Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$28,882,484
+$1,396,918 QoQ
Shares Held
113,724
+1.1% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
6.94%
of 13F equity value
Holder Rank
#606
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Glen Eagle Advisors, LLC holds $41,817,560 across 12 Drug Manufacturers - General names. JNJ ranks #1 (69.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
113,724 | $28,882,484 | |
| 2 | ABBV |
AbbVie Inc.
|
21,140 | $5,319,669 | |
| 3 | LLY |
ELI LILLY & Co
|
3,599 | $4,316,748 | |
| 4 | MRK |
Merck & Co., Inc.
|
8,886 | $1,141,851 | |
| 5 | PFE |
Pfizer Inc
|
30,849 | $742,843 | |
| 6 | AMGN |
Amgen Inc
|
1,750 | $633,710 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,641 | $267,414 | |
| 8 | GSK |
GSK plc
|
4,548 | $238,406 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,882,484 | 113,724 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $27,485,566 | 112,443 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $23,432,120 | 113,226 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $21,169,030 | 114,168 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $16,454,230 | 107,720 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $17,642,722 | 106,384 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $15,457,564 | 106,884 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $17,413,184 | 107,449 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $16,224,636 | 111,006 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $18,438,310 | 116,558 | Shares | Sole | 2024-07-03 | |
| 2023-12-31 | $18,685,288 | 119,212 | Shares | Sole | 2024-08-13 | |
| 2023-09-30 | $18,647,013 | 119,724 | Shares | Sole | 2024-08-13 | |
| 2023-06-30 | $19,611,140 | 118,482 | Shares | Sole | 2024-08-13 | |
| 2023-03-31 | $18,048,975 | 116,445 | Shares | Sole | 2024-08-13 | |
| 2022-12-31 | $19,961,096 | 112,998 | Shares | Sole | 2024-08-13 | |
| 2022-09-30 | $18,310,042 | 112,084 | Shares | Sole | 2024-08-13 | |
| 2022-06-30 | $20,795,829 | 117,153 | Shares | Sole | 2024-08-13 | |
| 2022-03-31 | $19,834,872 | 111,916 | Shares | Sole | 2024-08-13 | |
| 2021-12-31 | $19,239,216 | 112,464 | Shares | Sole | 2024-08-13 | |
| 2021-09-30 | $17,967,359 | 111,253 | Shares | Sole | 2024-08-13 | |
| 2021-06-30 | $16,866,410 | 102,382 | Shares | Sole | 2024-08-13 | |
| 2021-03-31 | $16,665,090 | 101,400 | Shares | Sole | 2024-08-13 | |
| 2020-12-31 | $15,728,399 | 99,939 | Shares | Sole | 2024-08-13 | |
| 2020-09-30 | $14,648,749 | 98,393 | Shares | Sole | 2024-08-13 | |
| 2020-06-30 | $13,495,557 | 95,965 | Shares | Sole | 2024-08-13 | |
| 2020-03-31 | $1,865,717 | 14,228 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||